glp 1 receptor agonists incretin mimetics Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus The Benefits of Incretin Mimetics
Description
So the path looks indirect
107 These effects all result in a slower and steadier uptake of nutrients into the circulation
J Biol Chem 263: 1347513478, 1988
In 2017, a multicenter study of 313 sites showed that only 6% of patients who were eligible to receive GLP-1 agonists were given this class of medication [126]
With medical supervision both can be appropriate complementary additions without supervision the combined effect requires monitoring
